Scleredema
Scleredema (also called scleredema of Buschke) is a rare connective tissue disorder marked by symmetrical, non-pitting thickening and hardening of the skin and the tissue beneath it. At its core, scleredema results from an abnormal buildup of mucopolysaccharides (mainly hyaluronic acid) in the extracellular matrix of the dermis, which drives fibroblasts to multiply and produce more type I collagen.
Unlike systemic sclerosis, which damages blood vessels and thins the skin of the fingers and toes, scleredema mainly affects the thick skin of the upper trunk. It starts at the back of the neck and spreads symmetrically to the shoulders, upper back, face and chest. Mucin deposition and fibrosis rob the skin of its natural elasticity, leaving it hard as wood or leather and severely restricting movement of the neck, shoulders and chest.
At Haute-Derma, we classify scleredema into three classic clinical types according to the associated cause:
- Type 1 (post-infectious): usually begins abruptly after an acute respiratory infection (most often group A beta-hemolytic streptococcus). It mainly affects children and young women and tends to be self-limiting, resolving on its own over months to a few years.
- Type 2 (idiopathic / paraproteinemia-associated): develops slowly and silently with no preceding infection, and is often linked to blood disorders, particularly monoclonal gammopathy or multiple myeloma.
- Type 3 (diabetes-associated, scleredema diabeticorum): typically seen in middle-aged men with long-standing, poorly controlled (insulin-dependent) diabetes. This type is chronic and persistent, and responds very poorly to standard treatments.
Our Approach to Treating Scleredema
Scleredema is not a superficial cosmetic concern but a deep dermal infiltration syndrome, and at Haute-Derma we manage it with a multimodal strategy:
- Broad screening for underlying causes: we look beyond the skin with a full workup, from streptococcal antibodies (ASO) and blood sugar markers (HbA1c) to serum protein electrophoresis (SPEP), to rule out hidden internal malignancy.
- Treatment tailored to disease type: we pinpoint the type (diabetic, post-infectious or blood-disorder related) and work with endocrinologists and hematologists to build a targeted plan for each patient.
- Combined specialist technologies: we pair local therapies that suppress fibroblasts with advanced physical therapy to restore as much range of motion as possible and prevent restriction of the breathing muscles.
How We Diagnose Scleredema at Haute-Derma
To confirm scleredema and reliably distinguish it from other scleroderma-like conditions, Haute-Derma follows a standardized workup:
Clinical Examination and Mechanical Function Assessment
- The dermatologist palpates the skin and assesses how hard it is. Affected areas have poorly defined borders and thickened skin that cannot be pinched into a fold. The surface may be smooth and shiny or have an orange-peel texture (peau d'orange) because the pores are pulled inward.
- We assess how far the neck can move (patients often struggle to turn, bend or tilt the head back) and measure chest expansion to screen for restricted breathing.
Deep Skin Biopsy
This is the gold standard for confirming the diagnosis. The sample must be deep enough to include the subcutaneous fat:
- Routine H&E staining: shows a dermis two to three times thicker than normal, with swollen collagen fibers separated by clear spaces (from edema). Thick collagen bundles partly replace the subcutaneous fat. Importantly, there is no inflammatory infiltrate around the blood vessels, and the skin appendages (sweat glands, hair follicles) are not atrophied as they are in scleroderma.
- Special stains (Alcian blue or colloidal iron): these highlight blue-staining bands of mucopolysaccharides (mucin) between the collagen bundles, confirming the matrix infiltration characteristic of the disease.
Laboratory Tests to Screen for Complications and Underlying Disease
- Biochemistry: fasting blood glucose and HbA1c (to assess diabetes).
- Immunology and hematology: serum and urine immunofixation electrophoresis and free light chain levels to screen for myeloma.
- Imaging: a chest X-ray or pulmonary function tests if there is shortness of breath or a choking sensation when swallowing (from mucin infiltrating the esophagus or diaphragm).
How Scleredema Is Treated at Haute-Derma
Because the disease mechanism is complex, especially in the chronic diabetes-related form, treatment at Haute-Derma flexibly combines management of the root cause with care of the skin symptoms:
Tight Control of the Underlying Condition
- Patients with diabetes: the top priority is optimizing blood sugar. Bringing HbA1c into a safe range under an endocrinologist's supervision is essential to stop fibroblasts from producing more abnormal mucin.
- Post-infectious type: fully treat any remaining ear, nose or throat infection.
Systemic, Anti-Inflammatory and Anti-Fibrotic Therapy
- Oral or pulse corticosteroids: usually considered for rapidly progressive, florid type 1 disease to quickly shut down the inflammation that stimulates fibroblasts.
- Immunomodulating and anti-fibrotic drugs: in chronic, treatment-resistant cases, your doctor may add methotrexate or cyclosporine to curb excessive collagen production.
- Local mucin-dissolving therapy: for some localized cases, hyaluronidase can be micro-injected directly into the affected skin to break down hyaluronic acid molecules and soften the tissue quickly.
Light-Based Therapy and Advanced Physical Therapy
- Phototherapy (UVA1 / PUVA): short-wavelength UVA1 ultraviolet light is directed at the hardened skin. UVA1 penetrates deep into the dermis and prompts macrophages to secrete matrix metalloproteinase-1 (MMP-1), a natural enzyme that cuts and breaks down excess collagen bundles, softening the skin and restoring its elasticity.
- Physical therapy to free up movement: patients follow a program of neck, shoulder and chest stretches combined with targeted heat therapy to release joint stiffness and preserve lung vital capacity.
